The total return over the past 12 months is +46.58% vs. +16.94% for the S&P 500. So far it's up +80.85% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +46.58% | +89.65% | +10.75% | +20.46% | +15.52% | N/A |
| Total Return CAGR | +46.58% | +89.65% | +10.75% | +20.46% | +15.52% | N/A |
| Revenue CAGR | +76.08% | +221.45% | +219.22% | +135.53% | N/A | N/A |
| Net Income CAGR | +630.24% | N/A | N/A | N/A | +47.81% | N/A |
| EPS CAGR | +634.60% | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
TG Therapeutics, Inc. (TGTX)
| Year | Start price | End price | TGTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $29.81 | $53.91 | +80.85% | +14.51% | +66.34% |
| 2025 | $30.10 | $29.81 | (0.96%) | +17.72% | (18.68%) |
| 2024 | $17.08 | $30.10 | +76.23% | +24.89% | +51.34% |
| 2023 | $11.83 | $17.08 | +44.38% | +26.19% | +18.19% |
| 2022 | $19.00 | $11.83 | (37.74%) | (18.17%) | (19.57%) |
| 2021 | $52.02 | $19.00 | (63.48%) | +28.74% | (92.22%) |
| 2020 | $11.10 | $52.02 | +368.65% | +18.37% | +350.28% |
| 2019 | $4.10 | $11.10 | +170.73% | +31.22% | +139.51% |
| 2018 | $8.20 | $4.10 | (50.00%) | (4.56%) | (45.44%) |
| 2017 | $4.65 | $8.20 | +76.34% | +21.70% | +54.64% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
